Le Lézard
Classified in: Health
Subjects: SVY, TDS, ASI

The Evolution Of Clinical Research In East Asia

NEW YORK, June 9, 2015 /PRNewswire/ -- Citeline®, an Informa business unit, and the pharmaceutical industry's leading research authority on clinical trials, reported today that clinical trials in East Asia have increased dramatically over a recent 10 year period, driven primarily by local studies conducted by a single sponsor.

The findings were presented today at the Pharma CI Conference & Exhibition Asia in Tokyo Japan, an event attended by top competitive intelligence professionals in the Japanese pharmaceutical industry. The full report, written by Doro Shin, a well published Citeline analyst, is now publically available.

For her analysis, Ms. Shin used Citeline's Trialtrove® and Trialpredict®, competitive intelligence resources that draw data from over 30,000 sources. The report focuses on Phase I-III industry sponsored trials located in China, Hong Kong, Japan, South Korea and/or Taiwan that were initiated or planned in 2002-2012. While Japan leads the group, as expected, with the largest number of trials, there is a clear rise in the number of trials located in China and South Korea and drop in Hong Kong.

The analysis reveals that 65% of all these trials took place in a single East Asian country, with a high of 78% of Japan's initiated studies involving only local sites compared to 55% in China. In other countries such as South Korea, the majority of trials initiated were part of a larger multinational study.

Phase 1 activity appears to be increasing while the number of Phase III trials remains steady. The most common therapeutic area is oncology, however the top indications for initiated and planned trials are not limited to cancer.

"When looking at who is conducting the trials, there is a very diverse set of players," commented Ms. Shin, "Large multinational companies such as Novartis and Roche, and local headquartered companies such as Takeda and Otsuka, initiated hundreds of their own trials, however overall there were 617 different companies with an average of only 16 trials each. And for this part of the globe, a surprisingly small number of trials involved collaborations between sponsors."

The full report also covers the indications being studied and enrollment trends by phase, location and disease as well as a detailed look into characteristics of new trials currently being planned in East Asia.

The report published today reflects Citeline's continuing efforts to bring relevant analysis to the industry through thought leadership.

To view the full analysis please download the free report ? The Evolution of Clinical Research in East Asia.         

About Citeline

Citeline delivers the pharmaceutical industry's most robust, reliable, and relevant R&D intelligence?all with direct, unlimited analyst support. Citeline's suite of fully integrated solutions features an unmatched data collection of global clinical trials, drug development pipelines, investigators and site profiles. Citeline data is drawn from over 30,000 unique sources and updated in real-time by the industry's largest team of expert analysts and editors.

Contact for Further Information
Julie McKenna
Product Marketing Manager
Citeline Inc.

SOURCE Citeline

These press releases may also interest you

at 12:29
The American College of Emergency Physicians (ACEP) and the Medical Association of Georgia (MAG) today filed suit against Anthem's Blue Cross Blue Shield of Georgia in federal court in an effort to compel the insurance giant to rescind its...

at 12:15
CHARLESTON, S.C., July 17, 2018 /PRNewswire-PRWeb/ -- A dentist dedicated to comfortable and effective care, Dr. Kevin Hogan welcomes new patients in Charleston, SC for Invisalign® clear braces with or without a referral. The leading alternative to...

at 12:15
Spectrum Health today announced that its System Board of Directors has appointed Tina Freese Decker as the health system's next President and Chief Executive Officer.  Freese Decker has been with Spectrum Health since 2002 and most recently was...

at 12:15
Crunch Franchise today announced that 1,536 people signed up for memberships for the Crunch gym opening in Tuscaloosa, Alabama, on the first day they became available. That figure sets a Crunch Franchise record for the most memberships sold during...

at 12:01
CoNextions Inc. (www.conextionsmed.com) announced today that its has enrolled its first two patients in a multicenter, blinded, randomized clinical trial  comparing the CoNextions TR System to standard of care suture repair for repair of Zone 2...

at 12:00
"My friends with allergies are in a bind because they cannot keep their windows open to allow fresh air in on nice days," said an inventor from Ford City, Pa. "To help them out, I came up with an invention that filters allergens and pollutants from...

News published on 9 june 2015 at 14:15 and distributed by: